Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III observer-blind study of FLU New Generation vaccine versus Fluarix in previously vaccinated adults and elderly subjects
2008-002362-66Phase 3Completed
- Sponsor
- GSK
- Start
- Jul 2008
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, single-blind trial of Fluarix in influenza (3 arms), sponsored by GSK. Primary endpoint: Solicited local symptoms within 7 days after vaccination. Started Jul 2008; status: completed.
02
Drugs
Fluarix
03
Conditions
influenza
Beyond the preview
Go deeper on 2008-002362-66.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-002362-66.